Based on these premises, in agreement with Lui et al.’s suggestions, we look forward to a more suitable clinical scoring system, able to overcome the present limitations. At the same time, we also hope for a further role of thyroid function in a smarter biochemical panel for COVID-19 disease stratification.
Response to Letter to the Editor from Lui et al.: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS‑CoV‑2 disease’: prognostic signifcance of non‑thyroidal illness syndrome in the whole spectrum of COVID‑19 severity / C Sparano, M Maggi, L Petrone. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 0391-4097. - ELETTRONICO. - 45:(2022), pp. 903-904. [10.1007/s40618-021-01733-y]
Response to Letter to the Editor from Lui et al.: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS‑CoV‑2 disease’: prognostic signifcance of non‑thyroidal illness syndrome in the whole spectrum of COVID‑19 severity
C Sparano;M Maggi;
2022
Abstract
Based on these premises, in agreement with Lui et al.’s suggestions, we look forward to a more suitable clinical scoring system, able to overcome the present limitations. At the same time, we also hope for a further role of thyroid function in a smarter biochemical panel for COVID-19 disease stratification.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Petrone L et al., 2022.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
320.22 kB
Formato
Adobe PDF
|
320.22 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
